PATENT CLAIM ANALYSIS

Application Number: 15936659
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "264100"]

Abstract:
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6.7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and N-[(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

Claim (Index 1):
A combination comprising:\n (i) a compound of Structure (I): or a pharmaceutically acceptable salt or solvate thereof; and (ii) a compound of Structure (II): or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 90.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13699077', '13991576', '14893746', '14103092', '14044139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685606436399341
- 35 USC 102 Novelty (BERT): 0.611365861528879
- Combined Prediction Score: 0.7528411654288286
- Mean Citation Score: 444.208222
- Max Citation Score: 520.3807400000002
- Similarity Product: 515.1603123922303

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test